Cargando…
Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients.
BACKGROUND: Reactions are commonly associated with the chemotherapy of onchocerciasis. However unmanageable reactions are uncommon when ivermectin (Mectizan(®)) is used for the treatment of this infection, and this drug has proved to be a great improvement over previously used agents. Serious advers...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2003
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2147659/ https://www.ncbi.nlm.nih.gov/pubmed/14975062 http://dx.doi.org/10.1186/1475-2883-2-S1-S5 |